Regulators are supposed to abide by society's “bargain” with them: Civil servants are granted lifetime tenure and protected from political pressure and retaliation, and in return, they are supposed to ...

Researchers have created a slow-release ‘smart’ insulin that responds to blood glucose levels to provide week-long control with virtually no incidents of low blood sugar. Tested in mice and minipigs, ...

A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily ...

Co announces an expansion of its agreement with Novo Nordisk (NVO) to provide the biopharmaceutical mkt with recombinant human insulin, a key cell culture supplement used to manufacture biologic drugs ...

Type 2 diabetes accounts for 90% of all diabetes cases, with social risk factors such as high BMI, poor diet, environmental hazards, and low physical activity contributing to the burden. Ongoing ...

The U.S. Consumer Financial Protection Bureau issued a list on Friday of nearly 70 policy and regulatory guidance documents stretching back more than a decade that the agency plans to rescind.

Preliminary results from a phase II study of ARQ 197 in patients with microphthalmia transcription factor family (MiT)-associated tumors ...